Gary was the President of Bioprocessing, a specialized diagnostic reagent company that he founded in 1991. He was responsible for business development and planning, and contributed to new product and services development as well as sales and marketing. In 2012 Bioprocessing was acquired by Bio-Rad Laboratories. Currently, Gary continues to pursue his relationship with Bio-Rad as a consultant. Gary has over 35 years of diverse biotechnology-related industrial experience including cancer research, clinical lab work and management, biochemical industry R&D, and diagnostic reagent development and manufacturing. He holds an MBS in Clinical Chemistry from Northeastern University and a BS in Biochemistry from the University of Vermont. Gary also holds an ASCP (SC) certification as a technologist in Chemistry.